开云app官网登录入口网页版-官方正版

#多肽#

38篇内容 | 1366人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1530059, encodeId=7b4915300591f, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=Gut：赵方庆团队开发靶向菌肠脑轴的新型减肥多肽药物, objectType=article, longId=732008, objectId=546ce3200898, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=546ce3200898, replyNumber=0, likeNumber=87, createdTime=2022-07-12, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=546ce3200898, moduleTitle=Gut：赵方庆团队开发靶向菌肠脑轴的新型减肥多肽药物, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=546ce3200898)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530058, encodeId=243015300581d, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=再生医学的新方向：多肽, objectType=article, longId=724470, objectId=4228e2447046, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4228e2447046, replyNumber=0, likeNumber=92, createdTime=2022-04-19, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4228e2447046, moduleTitle=再生医学的新方向：多肽, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=4228e2447046)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530057, encodeId=7ef4153005e39, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=脾多肽联合阿帕替尼治疗晚期胃癌的临床研究, objectType=article, longId=221025, objectId=d3a3221025cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3a3221025cb, replyNumber=0, likeNumber=68, createdTime=2021-11-27, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3a3221025cb, moduleTitle=脾多肽联合阿帕替尼治疗晚期胃癌的临床研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d3a3221025cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530056, encodeId=55e3153005601, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=Diabetologia：利用人类遗传数据研究葡萄糖依赖的促胰岛素多肽信号对心脏代谢的影响, objectType=article, longId=220504, objectId=d6c9220504fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6c9220504fc, replyNumber=0, likeNumber=90, createdTime=2021-11-18, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6c9220504fc, moduleTitle=Diabetologia：利用人类遗传数据研究葡萄糖依赖的促胰岛素多肽信号对心脏代谢的影响, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=d6c9220504fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530055, encodeId=192b1530055a1, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=FDA优先审评多肽-药物偶联物（PDC）Melflufen治疗难治性多发性骨髓瘤的申请, objectType=article, longId=200078, objectId=465a2000e861, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=465a2000e861, replyNumber=0, likeNumber=72, createdTime=2020-09-02, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=465a2000e861, moduleTitle=FDA优先审评多肽-药物偶联物（PDC）Melflufen治疗难治性多发性骨髓瘤的申请, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=465a2000e861)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530054, encodeId=5c6d1530054f7, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=PNAS：长效多肽药物CPT31治疗艾滋病，前景光明！, objectType=article, longId=199899, objectId=9201199899ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9201199899ad, replyNumber=0, likeNumber=92, createdTime=2020-08-26, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9201199899ad, moduleTitle=PNAS：长效多肽药物CPT31治疗艾滋病，前景光明！, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=9201199899ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530053, encodeId=533f153005343, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=Aging：线粒体多肽humanin可以调节寿命和健康, objectType=article, longId=196592, objectId=8179196592f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8179196592f1, replyNumber=0, likeNumber=89, createdTime=2020-06-29, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8179196592f1, moduleTitle=Aging：线粒体多肽humanin可以调节寿命和健康, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=8179196592f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530052, encodeId=da3a153005226, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=血管活性肠多肽（VIP）RLF-100治疗COVID-19相关急性呼吸窘迫：患者已入组, objectType=article, longId=195151, objectId=50f71951518c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50f71951518c, replyNumber=0, likeNumber=73, createdTime=2020-06-04, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50f71951518c, moduleTitle=血管活性肠多肽（VIP）RLF-100治疗COVID-19相关急性呼吸窘迫：患者已入组, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=50f71951518c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530051, encodeId=dd4b1530051de, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=J Periodontal Res：牙周膜细胞在RGD合成多肽结合物涂层上的功能和细胞表面特征, objectType=article, longId=194302, objectId=22781943028e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22781943028e, replyNumber=0, likeNumber=62, createdTime=2020-05-19, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22781943028e, moduleTitle=J Periodontal Res：牙周膜细胞在RGD合成多肽结合物涂层上的功能和细胞表面特征, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=22781943028e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530050, encodeId=e2de15300508e, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床, objectType=article, longId=193904, objectId=7e121939040f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e121939040f, replyNumber=0, likeNumber=53, createdTime=2020-05-12, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e121939040f, moduleTitle=新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=7e121939040f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530049, encodeId=903d1530049a2, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=PLoS One：包含一种新的抗菌合成多肽滴耳液在慢性化脓性中耳炎患者中的安全性和效果评估, objectType=article, longId=193316, objectId=c99519331662, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c99519331662, replyNumber=0, likeNumber=56, createdTime=2020-05-03, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c99519331662, moduleTitle=PLoS One：包含一种新的抗菌合成多肽滴耳液在慢性化脓性中耳炎患者中的安全性和效果评估, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=c99519331662)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530048, encodeId=72e11530048a3, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=Cancer Immunol Immunother：混合多肽疫苗组合多烯紫杉醇和地塞米松治疗去势抵抗性前列腺癌研究, objectType=article, longId=188409, objectId=717318840990, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=717318840990, replyNumber=0, likeNumber=110, createdTime=2020-02-21, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=717318840990, moduleTitle=Cancer Immunol Immunother：混合多肽疫苗组合多烯紫杉醇和地塞米松治疗去势抵抗性前列腺癌研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=717318840990)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530047, encodeId=df63153004e6d, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=中晟全肽：向全球药物研发机构免费开放超大型多肽库，快速推进抗2019-nCoV新药研究, objectType=article, longId=187452, objectId=73f818e4522e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73f818e4522e, replyNumber=0, likeNumber=57, createdTime=2020-02-06, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73f818e4522e, moduleTitle=中晟全肽：向全球药物研发机构免费开放超大型多肽库，快速推进抗2019-nCoV新药研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=73f818e4522e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530046, encodeId=81bf153004677, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=PLoS Pathog ：定向制导既可“双重打击”也可“一箭双雕”——抗艾滋病毒长效抑制多肽与广谱中和抗体的联用策略, objectType=article, longId=184407, objectId=db2a18440e83, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db2a18440e83, replyNumber=0, likeNumber=67, createdTime=2019-12-09, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db2a18440e83, moduleTitle=PLoS Pathog ：定向制导既可“双重打击”也可“一箭双雕”——抗艾滋病毒长效抑制多肽与广谱中和抗体的联用策略, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=db2a18440e83)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530045, encodeId=883415300459b, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=中晟全肽宣布完成A轮融资1亿元，打造全球多肽药物研发新引擎, objectType=article, longId=176265, objectId=35521e626537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35521e626537, replyNumber=0, likeNumber=68, createdTime=2019-07-28, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35521e626537, moduleTitle=中晟全肽宣布完成A轮融资1亿元，打造全球多肽药物研发新引擎, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=35521e626537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530044, encodeId=bec3153004496, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=短肠综合征：双效多肽药物ZP7570正在进行I期临床试验, objectType=article, longId=174327, objectId=f0d81e432731, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0d81e432731, replyNumber=0, likeNumber=94, createdTime=2019-06-29, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0d81e432731, moduleTitle=短肠综合征：双效多肽药物ZP7570正在进行I期临床试验, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=f0d81e432731)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530043, encodeId=9c6f1530043d3, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=Sci Rep：膀胱癌复发患者诊断评估中的尿液多肽分析, objectType=article, longId=167591, objectId=810616e591ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=810616e591ed, replyNumber=0, likeNumber=62, createdTime=2019-06-05, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=810616e591ed, moduleTitle=Sci Rep：膀胱癌复发患者诊断评估中的尿液多肽分析, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=810616e591ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530042, encodeId=c95b1530042f9, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=AmyPore治疗阿尔茨海默氏症和帕金森症的多肽药物，喜获欧盟资助, objectType=article, longId=167516, objectId=06c616e5160f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=06c616e5160f, replyNumber=0, likeNumber=65, createdTime=2019-06-04, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=06c616e5160f, moduleTitle=AmyPore治疗阿尔茨海默氏症和帕金森症的多肽药物，喜获欧盟资助, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=06c616e5160f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530041, encodeId=1f381530041d3, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=J Endod：增强弹性蛋白样多肽类基质对MTA物理特性的作用研究, objectType=article, longId=150842, objectId=5886150842b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5886150842b8, replyNumber=0, likeNumber=66, createdTime=2018-10-13, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5886150842b8, moduleTitle=J Endod：增强弹性蛋白样多肽类基质对MTA物理特性的作用研究, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=5886150842b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1530040, encodeId=636115300405f, content=<a href='/topic/show?id=fd6f4340017' target=_blank style='color:#2F92EE;'>#多肽#</a>, objectTitle=Diabetologia：多肽偶联的纳米颗粒在“人源化”的HLA-转基因小鼠中诱导耐受并抑制1型糖尿病中致糖尿病CD8+T细胞应答, objectType=article, longId=125246, objectId=1e7d12524641, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e7d12524641, replyNumber=0, likeNumber=74, createdTime=2018-01-02, rootId=0, userName=fusion, userId=cdb812012363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e7d12524641, moduleTitle=Diabetologia：多肽偶联的纳米颗粒在“人源化”的HLA-转基因小鼠中诱导耐受并抑制1型糖尿病中致糖尿病CD8+T细胞应答, moduleType=article, hrefUrl=//www.sandwebs.com/article/show_article.do?id=1e7d12524641)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

多肽

2020-05-29

fusion (审核中...)

前往app查看评论内容

#多肽#

Gut：赵方庆团队开发靶向菌肠脑轴的新型减肥多肽药物

2022-07-12

fusion (审核中...)

前往app查看评论内容

#多肽#

再生医学的新方向：多肽

2022-04-19

fusion (审核中...)

前往app查看评论内容

#多肽#

脾多肽联合阿帕替尼治疗晚期胃癌的临床研究

2021-11-27

fusion (审核中...)

前往app查看评论内容

#多肽#

Diabetologia：利用人类遗传数据研究葡萄糖依赖的促胰岛素多肽信号对心脏代谢的影响

2021-11-18

fusion (审核中...)

前往app查看评论内容

#多肽#

FDA优先审评多肽-药物偶联物（PDC）Melflufen治疗难治性多发性骨髓瘤的申请

2020-09-02

fusion (审核中...)

前往app查看评论内容

#多肽#

PNAS：长效多肽药物CPT31治疗艾滋病，前景光明！

2020-08-26

fusion (审核中...)

前往app查看评论内容

#多肽#

Aging：线粒体多肽humanin可以调节寿命和健康

2020-06-29

fusion (审核中...)

前往app查看评论内容

#多肽#

血管活性肠多肽（VIP）RLF-100治疗COVID-19相关急性呼吸窘迫：患者已入组

2020-06-04

fusion (审核中...)

前往app查看评论内容

#多肽#

J Periodontal Res：牙周膜细胞在RGD合成多肽结合物涂层上的功能和细胞表面特征

2020-05-19

fusion (审核中...)

前往app查看评论内容

#多肽#

新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床

2020-05-12

fusion (审核中...)

前往app查看评论内容

#多肽#

PLoS One：包含一种新的抗菌合成多肽滴耳液在慢性化脓性中耳炎患者中的安全性和效果评估

2020-05-03

fusion (审核中...)

前往app查看评论内容

#多肽#

Cancer Immunol Immunother：混合多肽疫苗组合多烯紫杉醇和地塞米松治疗去势抵抗性前列腺癌研究

2020-02-21

fusion (审核中...)

前往app查看评论内容

#多肽#

中晟全肽：向全球药物研发机构免费开放超大型多肽库，快速推进抗2019-nCoV新药研究

2020-02-06

fusion (审核中...)

前往app查看评论内容

#多肽#

PLoS Pathog ：定向制导既可“双重打击”也可“一箭双雕”——抗艾滋病毒长效抑制多肽与广谱中和抗体的联用策略

2019-12-09

fusion (审核中...)

前往app查看评论内容

#多肽#

中晟全肽宣布完成A轮融资1亿元，打造全球多肽药物研发新引擎

2019-07-28

fusion (审核中...)

前往app查看评论内容

#多肽#

短肠综合征：双效多肽药物ZP7570正在进行I期临床试验

2019-06-29

fusion (审核中...)

前往app查看评论内容

#多肽#

Sci Rep：膀胱癌复发患者诊断评估中的尿液多肽分析

2019-06-05

fusion (审核中...)

前往app查看评论内容

#多肽#

AmyPore治疗阿尔茨海默氏症和帕金森症的多肽药物，喜获欧盟资助

2019-06-04

heli0118 (审核中...)

前往app查看评论内容

#多肽#

J Endod：增强弹性蛋白样多肽类基质对MTA物理特性的作用研究

2018-10-13

fusion (审核中...)

前往app查看评论内容

#多肽#

Diabetologia：多肽偶联的纳米颗粒在“人源化”的HLA-转基因小鼠中诱导耐受并抑制1型糖尿病中致糖尿病CD8+T细胞应答

2018-01-02

科室
- - 订阅+
  - 更多科室
工具
服务